These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482 [TBL] [Abstract][Full Text] [Related]
4. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre. Pullerits R; Ljevak M; Vikgren J; Bokarewa M Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472 [TBL] [Abstract][Full Text] [Related]
5. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR; Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882 [TBL] [Abstract][Full Text] [Related]
14. [ANCA-associated forms of vasculitis]. Helmchen U; Kneissler U; Prall F Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053 [TBL] [Abstract][Full Text] [Related]
15. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Charles P; Néel A; Tieulié N; Hot A; Pugnet G; Decaux O; Marie I; Khellaf M; Kahn JE; Karras A; Ziza JM; Deligny C; Tchérakian C; Guillevin L; Rheumatology (Oxford); 2014 Mar; 53(3):532-9. PubMed ID: 24282319 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis. Lurati-Ruiz F; Spertini F J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696 [TBL] [Abstract][Full Text] [Related]
17. B-cell depleting agents for ANCA vasculitides: a new therapeutic approach. Gómez-Puerta JA; Quintana LF; Stone JH; Ramos-Casals M; Bosch X Autoimmun Rev; 2012 Jul; 11(9):646-52. PubMed ID: 22146313 [TBL] [Abstract][Full Text] [Related]
18. [Wegener's granulomatosis and microscopic polyangiitis]. Pagnoux C Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109 [TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases. Caravaca-Fontán F; Yerovi E; Delgado-Yagu E M; Galeano C; Pampa-Saico S; Tenorio MT; Liaño F Med Clin (Barc); 2017 Jan; 148(1):1-7. PubMed ID: 28196580 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Itabashi M; Takei T; Yabuki Y; Suzuki H; Ando M; Akamatsu M; Yamazaki M; Mitobe M; Watanabe Y; Mochizuki T; Nitta K Nephron Clin Pract; 2010; 115(1):c21-7. PubMed ID: 20173346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]